Comparing CJC-1295 (No DAC) and Ipamorelin — both manufactured, lyophilized and packaged in the USA — no overseas manufacturing, no imports. This research-use reference summarizes how each is classified and what each has been studied for.
Comparing CJC-1295 (No DAC) and Ipamorelin — both manufactured, lyophilized and packaged in the USA — no overseas manufacturing, no imports. This research-use reference summarizes how each is classified and what each has been studied for.
CJC-1295 (No DAC) is a ghrh analog. Studied as a long-acting growth-hormone-releasing hormone that sustains GH and downstream IGF-1 levels for tissue repair research. Our CJC-1295 (No DAC) is manufactured, lyophilized and packaged in the USA — no overseas manufacturing, no imports and third-party COA tested.
Ipamorelin is a gh secretagogue. Investigated for selective, pulsatile growth-hormone release without significant cortisol or prolactin elevation. Our Ipamorelin is manufactured, lyophilized and packaged in the USA — no overseas manufacturing, no imports and third-party COA tested.
Both CJC-1295 (No DAC) and Ipamorelin from PX1 are manufactured, lyophilized and packaged in the USA — no overseas manufacturing, no imports, with ISO 17025 third-party COAs available. All material is sold for laboratory and research use only — this page does not offer medical guidance or dosing.
What is the difference between CJC-1295 (No DAC) and Ipamorelin?
CJC-1295 (No DAC) is a ghrh analog; Ipamorelin is a gh secretagogue. Each has a distinct research profile — see the sections above.
Are both made in the USA?
Yes — both are manufactured, lyophilized and packaged in the USA — no overseas manufacturing, no imports and ship with third-party COAs available.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.